[ASAP] Pharmacokinetics and Biodistribution of < sup > 89 < /sup > Zr-Miltuximab and Its Antibody Fragments as Glypican ‑1 Targeting Immuno-PET Agents in Glioblastoma

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00760

Source: Molecular Pharmaceutics - January 5, 2023 Category: Drugs & Pharmacology Authors: Saikat Ghosh, Nicholas L. Fletcher, Pie Huda, Zachary H. Houston, Christopher B. Howard, Maria E. Lund, Yanling Lu, Douglas H. Campbell, Bradley J. Walsh, and Kristofer J. Thurecht Source Type: research